Philip L. Padou

Dionex Corp. develops, manufactures, sells, and services chromatography and extraction systems for separating, isolating, and identifying the components of chemical mixtures. The firm's products are used extensively by the environmental, life science, pharmaceutical, food and beverage, chemicals, electronics and power industries. The company was founded in 1975 and is headquartered in Sunnyvale, CA.

Part of GE Healthcare Technologies, Inc., OEC Medical Systems, Inc. is a company that develops, sells, and services X-ray and fluoroscopic imaging systems. The company is based in Salt Lake City, UT. The company was founded in 1942 by Al S. Waxman. OEC Medical Systems was acquired by GE Medical Systems, Inc. on November 29, 1999 for $444.47 million.

Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

RainDance Technologies, Inc. engages in the development and commercialization of professional laboratory system. It develops and manufactures genomic tools for non-invasive liquid biopsy applications for the research, early detection, treatment of cancer, and inherited and infectious diseases. The company was founded by Andrew Griffiths, Darren R. Link, and Jerome Bibette in 2004 and is headquartered in Billerica, MA.

GenapSys, Inc. develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing. It also develops gene electronic nano-integrated ultra-sensitive platform device for chip-based DNA sequencing. The company was founded by Hesaam Esfandyarpour in 2010 and is headquartered in Redwood, CA.

Sprout Group (Sprout) is venture capital subsidiary of Credit Suisse Private Equity LLC founded in 1969. The firm headquartered in New York.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of SCYNEXIS, Inc., Drug Discovery Facility provides research into drug-discovery processes. The company is based in Cambridge, UK. Drug Discovery Facility was acquired by SCYNEXIS, Inc. from Aventis Cropscience on October 02, 2001.

Alliance Technology Management Corp. (Alliance Technology Ventures) is an Independent Venture Capital firm founded in 1993 by Mike A. Henos. The firm is headquartered in US, Sarasota.

One Lambda, Inc. provides transplantation services. The firm offers antibody detection, serology, molecular typing instruments and software products. The company was founded by Paul I. Terasaki in 1984 and is headquartered in Canoga Park, CA.

PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium.

Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA.

Part of Advanced Medical Technology Association, AdvaMedDx operates as a trade association representing diagnostics manufacturers. The company is based in Washington. The CEO of the American company is Scott Whitaker.

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

Gyros Protein Technologies AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. It provides sample preparation, synthesis and bioanalytical tools for biotherapeutics discovery, development and bioprocessing. The company was founded in March 2016 and is headquartered in Uppsala, Sweden.

Canopy Biosciences LLC engages in the provision of products and services for gene editing, gene expression analysis and regulation, and bioprocessing. It offers crispr complete kits, mirna crispr knockout kits, clia certified services, compbio, mirna mimics, and cho complete. The company was founded by David Adam Smoller, Edward J. Weinstein and Crystal Winkeler in 2016 and is headquartered in St. Louis, MO.

Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA.

Leinco Technologies, Inc. is a specialty manufacturer of early discovery research products, including antibodies, recombinant proteins, ELISA kits, and other life sciences products. Leinco Technologies is based in St. Louis, MO, and operates out of a 27,000 square foot facility with significant laboratory space to service all customer and regulatory requirements. The company also offers a full suite of custom development and manufacturing services and serves leading drug discovery and in vitro diagnostic companies around the world. The company was founded in 1992 by Patrick Leinert, who has been the CEO since then.

Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020.

Bio-Rad SAS is a French company that specializes in developing and manufacturing products for the life science research and clinical diagnostic markets. The private company is based in Marnes-la-Coquette, France. The company's focus is on accelerating biopharmaceutical and biotherapeutic method, process development, manufacturing, release testing, quality control, and patient monitoring with resources and workflows. The company is committed to helping the scientific community change the world through innovative products. The company was founded in 2012. Norman D. Schwartz has been the CEO of the company since 2021.